Hostname: page-component-7b7567c8c-p67k6 Total loading time: 0 Render date: 2026-11-19T11:45:55.963Z Has data issue: false hasContentIssue false

Preventing Dementia

Published online by Cambridge University Press:  02 December 2014

S.E. Black
Affiliation:
Department of Medicine, Neurology, University of Toronto, Toronto, Canada
C. Patterson
Affiliation:
Geriatric Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
J. Feightner
Affiliation:
Family Medicine, University of Western Ontario, London, Ontario, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Primary prevention will become increasingly important as dementia prevalence increases and effective retardive therapies are developed. To date, only one randomized controlled trial (involving treatment of systolic hypertension) has demonstrated that the incidence of dementia can be reduced. Physicians should remain alert to possible secondary causes of dementia and correct these whenever possible. Primary and secondary prevention of stroke should reduce dementia related to cerebrovascular disease either directly or as a comorbid factor in Alzheimer’s disease (AD). Epidemiological studies have revealed a number of risk factors for AD including genetic mutation, susceptibility genes, positive family history, Down’s syndrome, age, sex, years of education, head trauma and neurotoxins. In case-control studies non-steroidal anti-inflammatory medication and estrogen replacement therapy appear to decrease the relative risk of developing AD. Further research to develop and test preventative therapies in AD and other dementias should be strongly encouraged.

Information

Type
Research Article
Copyright
Copyright © The Canadian Journal of Neurological 2001